Description
DAPZIGARD-5 is an SGLT2 inhibitor used in adults primarily for type 2 diabetes, but it also offers important benefits for heart failure and chronic kidney disease.
Uses / Indications
-
Type 2 Diabetes Mellitus: Lowers blood sugar when diet, exercise, or other antidiabetic agents are insufficient.
-
Heart Failure: Reduces risk of hospitalization and protects against worsening heart failure, even in non-diabetics in some cases.
-
Chronic Kidney Disease (CKD): Slows kidney disease progression, reduces risk of kidney failure, and lowers the chances of major heart or kidney events.
-
Shown to reduce overall cardiovascular death and complications in at-risk populations.
How it Works / Key Benefits
-
Mechanism: Blocks SGLT2 receptors in the kidney to increase urinary glucose excretion, lowering blood sugar without causing hypoglycemia alone.
-
Benefits include modest weight loss, mild blood pressure reduction, heart protection, and kidney preservation.
-
Not typically used for type 1 diabetes (due to risk of DKA) or in patients with severe kidney impairment.
Dosage & Administration
-
Taken once daily, either alone or alongside other diabetes or heart failure medications; dose and duration are prescribed individually.
-
Swallow whole with water, at the same time daily, with or without food.
-
Kidney function should be checked before and during therapy; dose is not started or continued if eGFR is below the recommended range.
Safety & Side Effects
-
Common: Genital yeast infection, urinary tract infection, increased urination, mild dehydration, thirst, nausea, constipation, or dizziness.
-
Occasional/serious: Ketoacidosis (even with normal sugar), severe urinary tract infection, hypotension, increased cholesterol, rare severe allergic reactions.
-
Not for pregnancy, breastfeeding, type 1 diabetics, or in children under 18 without specialist advice.
-
Hydration and regular sugar/urine monitoring are recommended.
Note:
DAPZIGARD-5 is a long-term therapy for type 2 diabetes, heart failure, or CKD. It is best used as part of a comprehensive care plan—only under medical supervision with regular checkups.
Leave a Reply